RT Journal Article
SR Electronic
T1 Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside?
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003487
DO 10.1136/jitc-2021-003487
VO 10
IS 5
A1 Guedan, Sonia
A1 Luu, Maik
A1 Ammar, Delphine
A1 Barbao, Paula
A1 Bonini, Chiara
A1 Bousso, Philippe
A1 Buchholz, Christian J
A1 Casucci, Monica
A1 De Angelis, Biagio
A1 Donnadieu, Emmanuel
A1 Espie, David
A1 Greco, Beatrice
A1 Groen, Richard
A1 Huppa, Johannes B
A1 Kantari-Mimoun, Chahrazade
A1 Laugel, Bruno
A1 Mantock, Mary
A1 Markman, Janet L
A1 Morris, Emma
A1 Quintarelli, Concetta
A1 Rade, Michael
A1 Reiche, Kristin
A1 Rodriguez-Garcia, Alba
A1 Rodriguez-Madoz, Juan Roberto
A1 Ruggiero, Eliana
A1 Themeli, Maria
A1 Hudecek, Michael
A1 Marchiq, Ibtissam
YR 2022
UL http://jitc.bmj.com/content/10/5/e003487.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.